Point-Counterpoint: Selective Laser Trabeculoplasty Versus Topical Medication for Initial Intraocular Pressure Lowering in Primary Open-Angle Glaucoma and Ocular Hypertension
Clinical Insights in Eyecare · 28.06.2024 · 2 (3)
DOI: 10.66574/001c.120399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Insights in Eyecare, online erschienen am 28.06.2024. Verfasst von Sarah MacIver und 3 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
MacIver, S., Amin, P., Ballinger, R., & Sullivan-Mee, M. (2024). Point-Counterpoint: Selective Laser Trabeculoplasty Versus Topical Medication for Initial Intraocular Pressure Lowering in Primary Open-Angle Glaucoma and Ocular Hypertension. Clinical Insights in Eyecare, 2(3). https://doi.org/10.66574/001c.120399
Vancouver
MacIver S, Amin P, Ballinger R, Sullivan-Mee M. Point-Counterpoint: Selective Laser Trabeculoplasty Versus Topical Medication for Initial Intraocular Pressure Lowering in Primary Open-Angle Glaucoma and Ocular Hypertension. Clinical Insights in Eyecare. 2024;2(3). doi:10.66574/001c.120399
BibTeX
@article{MacIver2024,
author = {MacIver, Sarah and Amin, Pathik and Ballinger, Rex and Sullivan-Mee, Michael},
title = {Point-Counterpoint: Selective Laser Trabeculoplasty Versus Topical Medication for Initial Intraocular Pressure Lowering in Primary Open-Angle Glaucoma and Ocular Hypertension},
journal = {Clinical Insights in Eyecare},
year = {2024},
volume = {2},
number = {3},
doi = {10.66574/001c.120399}
}
EUVIMED